Evidence map›Paper›PMID 39466365›Full record

ArticleDermatology and therapy2024

Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National Survey.

Meredith T Polaskey, Lakshi Aldredge, Candrice Heath, Moises Acevedo, David H Chu, Diane Hanna, Melissa S Seal, Matthew Zirwas, Raj Chovatiya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Meredith T PolaskeyChicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
Lakshi AldredgeVeterans Administration Portland Health Care System, Portland, OR, USA.
Candrice HeathTemple University, Philadelphia, PA, USA.
Moises AcevedoInfinity Dermatology, New York, NY, USA.
David H ChuArcutis Biotherapeutics, Inc., Westlake Village, CA, USA.
Diane HannaArcutis Biotherapeutics, Inc., Westlake Village, CA, USA.
Melissa S SealArcutis Biotherapeutics, Inc., Westlake Village, CA, USA.
Matthew ZirwasDermatology of the Central States, Bexley, OH, USA.
Raj ChovatiyaChicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA. raj.chovatiya@gmail.com.ORCID http://orcid.org/0000-0001-6510-399X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSeborrheic dermatitis (SD) is a common, chronic inflammatory skin disease, but the physical and emotional burden of patients with SD experience has not been well characterized.

methodsThe Harris Poll conducted online surveys of US patients and healthcare providers (HCPs) from December 2021 to January 2022.

resultsAlmost half of patients reported that SD negatively impacts their emotional and physical well-being "a lot/a great deal"; HCPs underestimate the level of impact on patients. Most patients with SD reported a significant mental health impact, including anxiety, depression, anxiety about interacting with other people, and isolation. Two-thirds of patients said they did not know anyone else who had been diagnosed with SD, and even after diagnosis, less than half of patients still said they did not know anyone else with SD. Nearly all patients and HCPs agreed that it was challenging to hide SD symptoms, and most patients felt embarrassed when people commented on their SD symptoms. Most patients agreed that they would be further along in their career if they did not have SD, and SD symptoms made them less confident at work and less likely to want to interact with people at work. Almost half of patients reported ever missing work as a result of SD symptoms.

conclusionThese insights emphasize the physical and emotional patient burden associated with SD, impacting all aspects of patients' lives. Graphical abstract available for this article.

Indexed as

Disease burdenHealthcare provider-reported outcomesPatient-reported outcomesSeborrheic dermatitis

Identifiers

PMID39466365
PMCPMC11557741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.